Xponance’s Helmerich & Payne HP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Buy
10,550
+533
+5% +$19.9K ﹤0.01% 1322
2026
Q1
$361K Buy
10,017
+1,599
+19% +$54.5K ﹤0.01% 1174
2025
Q4
$241K Buy
+8,418
New +$224K ﹤0.01% 1292
2025
Q2
Sell
-8,294
Closed -$217K 1523
2025
Q1
$217K Buy
8,294
+587
+8% +$17.1K ﹤0.01% 1242
2024
Q4
$247K Buy
+7,707
New +$262K ﹤0.01% 1202
2024
Q3
Sell
-6,163
Closed -$223K 1394
2024
Q2
$223K Buy
6,163
+240
+4% +$9.23K ﹤0.01% 1146
2024
Q1
$249K Sell
5,923
-7
-0.1% -$265 ﹤0.01% 1120
2023
Q4
$215K Buy
5,930
+17
+0.3% +$657 ﹤0.01% 1136
2023
Q3
$249K Sell
5,913
-76
-1% -$3.17K ﹤0.01% 1076
2023
Q2
$212K Hold
5,989
﹤0.01% 1133
2023
Q1
$214K Buy
5,989
+55
+0.9% +$2.37K ﹤0.01% 1116
2022
Q4
$294K Buy
5,934
+95
+2% +$4.52K ﹤0.01% 1041
2022
Q3
$216K Buy
5,839
+250
+4% +$10.5K ﹤0.01% 1076
2022
Q2
$241K Buy
5,589
+686
+14% +$31.9K ﹤0.01% 1055
2022
Q1
$210K Buy
+4,903
New +$169K ﹤0.01% 1098

Other funds holding HP

Xponance's HP Position: Q2 2026 in Review

Xponance increased its Helmerich & Payne (HP) stake by 5.3% in Q2 2026, buying an estimated $19.9K and bringing the position to 10,550 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Xponance first reported a position in HP in Q1 2022 and has held it in 15 quarters since. The position peaked at $361K in Q1 2026. 374 funds tracked by Wall St. Rank hold HP as of Q2 2026.

  • Xponance held 10,550 shares of Helmerich & Payne worth $345K as of Q2 2026.
  • Xponance bought 533 Helmerich & Payne shares in Q2 2026, an estimated $19.9K.
  • Helmerich & Payne made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1322 holding.
  • Xponance first reported a position in Helmerich & Payne in Q1 2022 and has held it in 15 quarters since.
  • Xponance's Helmerich & Payne position peaked at $361K in Q1 2026.
  • 374 funds tracked by Wall St. Rank held Helmerich & Payne as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.